(CBS DETROIT) - State health officials are recommending the new 2023 COVID-19 vaccine for everyone six months and older for the fall and winter seasons following its approval for use. The Food and Drug Administration, the U.S. Centers for Disease Control and the Prevention...
During the 2023-24 respiratory virus season, the Advisory Committee on Immunization Practices recommends influenza and COVID-19 vaccines for all persons aged =6 months, and respiratory syncytial virus (RSV) vaccine is recommended for persons aged =60 years (using shared clinical ...
This reformulation is why health officials are calling this year's shots the "2023-2024 COVID-19 vaccine" or simply the "updated COVID-19 vaccine" —no longer using the word "boosters,"like additional doses have been called in previous rollouts. All Americans, including children as young a...
2020, Donald Trump promised to, “produce a vaccine before the end of the year, or maybe even sooner” (Reich and Masket2020). Trump added, “Nobody thought it could be done this fast. Normally it would be years, and we did it in a matter of a few months. We...
0:19 min Should children get a COVID-19 booster? 0:33 min Is it better to wait to get a COVID-19 vaccine that is adapted to currently circulating variants? 0:26 min Who should get COVID-19 vaccination booster doses? 1:03
This season’s vaccine is tailored to the SARS-CoV-2 XBB.1.5 sublineage and indicated as a single dose for most individuals 5 years of age and older Pre-clinical data show that the updated COVID-19 vaccine generates improved neutralizing antibody respons
The ACIP also held special meetings on September 12 and September 22 to discuss COVID-19 2023-2024 vaccine recommendations and RSV immunization in pregnant women. This update summarizes the proceedings of these meetings that are most relevant to the pediatric population. Major updates for pediatric ...
Centers for Disease Control and Prevention. COVID Data Tracker. Last updated September 7, 2023. Accessed September 11, 2023. https://covid.cdc.gov/covid-data-tracker/#datatracker-home Pfizer. Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine. Press release. Publi...
FDA and CDC say yes to new COVID shots for fall — here's what to know The new shots are similar to previously approved formulas but were updated to target strains of the virus descended from Omicron. Sep 15, 2023 Pittsburgh Regional Transit dropping COVID-19 vaccine requirements for employ...
2.3. Fall 2023 Vaccine Effectiveness Inputs Japanese Vaccine Effectiveness Real-Time Surveillance for SARS-CoV-2 (VERSUS) is an ongoing test-negative case-control study examining the VE of the COVID-19 vaccines in individuals aged 16 years and over [29]. Results are reported by different time...